A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells

Overview

This article describes the production strategy of integrase-deficient lentiviral vectors (IDLVs) for delivering CRISPR/Cas9 to cells. IDLVs offer a safer and effective platform for gene delivery, facilitating rapid gene editing in various cell types.

Key Study Components

Area of Science

• Gene editing
• CRISPR/Cas9 technology
• Lentiviral vector development

Background

• Integrase-deficient lentiviral vectors (IDLVs) are a novel approach for gene delivery.
• CRISPR/Cas9 is a powerful tool for gene editing.
• IDLVs provide a safer alternative to integrase-competent vectors.
• The protocol aims to optimize the production of IDLVs for efficient gene editing.

Purpose of Study

• To describe the production of optimized IDLVs.
• To explore the applications of IDLVs in gene editing.
• To demonstrate the efficiency of IDLVs in delivering CRISPR/Cas9 transgenes.

Methods Used

• Transfection of HEK-293T cells with optimized IDLVs.
• Preparation of culture media for transfection.
• Monitoring cell confluency prior to transfection.
• Evaluation of gene editing efficiency in target cells.

Main Results

• IDLVs effectively deliver CRISPR/Cas9 for gene editing.
• The production protocol yields highly concentrated IDLVs.
• IDLVs show efficiency in both in vivo and in vitro settings.
• Results indicate a robust gene editing capability in target cells.

Conclusions

• IDLVs are a promising tool for gene delivery and editing.
• They provide a safer alternative to traditional lentiviral vectors.
• The optimized production method enhances their application in research.

Frequently Asked Questions